BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9103385)

  • 1. Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines.
    Gibb RK; Taylor DD; Wan T; O'Connor DM; Doering DL; Gerçel-Taylor C
    Gynecol Oncol; 1997 Apr; 65(1):13-22. PubMed ID: 9103385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taxol-induced bcl-2 phosphorylation in ovarian cancer cell monolayer and spheroids.
    Makhija S; Taylor DD; Gibb RK; Gerçel-Taylor C
    Int J Oncol; 1999 Mar; 14(3):515-21. PubMed ID: 10024685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
    Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol.
    Perego P; Romanelli S; Carenini N; Magnani I; Leone R; Bonetti A; Paolicchi A; Zunino F
    Ann Oncol; 1998 Apr; 9(4):423-30. PubMed ID: 9636834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxol-induced cell cycle arrest and apoptosis: dose-response relationship in lung cancer cells of different wild-type p53 status and under isogenic condition.
    Das GC; Holiday D; Gallardo R; Haas C
    Cancer Lett; 2001 Apr; 165(2):147-53. PubMed ID: 11275363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
    Frankel A; Buckman R; Kerbel RS
    Cancer Res; 1997 Jun; 57(12):2388-93. PubMed ID: 9192815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR; Abel G
    Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of p53 and apoptosis in sensitization of cis-diamminedichloroplatinum antitumor activity by interleukin-1 in ovarian carcinoma cells.
    Song K; Fukushima P; Seth P; Sinha BK
    Int J Oncol; 1998 Feb; 12(2):299-304. PubMed ID: 9458352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells.
    Zaffaroni N; Silvestrini R; Orlandi L; Bearzatto A; Gornati D; Villa R
    Br J Cancer; 1998 May; 77(9):1378-85. PubMed ID: 9652752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Yamamoto K; Kikuchi Y; Kudoh K; Nagata I
    J Cancer Res Clin Oncol; 2000 Mar; 126(3):168-72. PubMed ID: 10741911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel sensitivity correlates with p53 status and DNA fragmentation, but not G2/M accumulation.
    Rakovitch E; Mellado W; Hall EJ; Pandita TK; Sawant S; Geard CR
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1119-24. PubMed ID: 10421546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
    Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
    Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms in the antiproliferative action of taxol and tiazofurin.
    Olah E; Csokay B; Prajda N; Kote-Jarai Z; Yeh YA; Weber G
    Anticancer Res; 1996; 16(5A):2469-77. PubMed ID: 8917337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines.
    Ormerod MG; O'Neill C; Robertson D; Kelland LR; Harrap KR
    Cancer Chemother Pharmacol; 1996; 37(5):463-71. PubMed ID: 8599870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines.
    Du YH; Ho PC
    Cancer Chemother Pharmacol; 2001 Jun; 47(6):481-90. PubMed ID: 11459200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
    O'Neill CF; Hunakova L; Kelland LR
    Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR; Fletcher B; Page C; Hu C; Nunez G; Baker V
    Gynecol Oncol; 1998 Sep; 70(3):398-403. PubMed ID: 9790794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular effects of taxol and caffeine on pancreatic cancer cells.
    Gururajanna B; Al-Katib AA; Li YW; Aranha O; Vaitkevicius VK; Sarkar FH
    Int J Mol Med; 1999 Nov; 4(5):501-7. PubMed ID: 10534572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.